Reprogramming method for induced pluripotent stem cells
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- ZONHON BIOPHARMA INST
- Publication Date
- 2017-07-04
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of cells, in particular to a method for reprogramming adult stem cells into induced pluripotent stem cells (iPSCs). Background technique
[0002] The inner cell mass in the blastocyst stage of the early vertebrate embryo is pluripotent, and it can differentiate into all types of cells in the three germ layers of the body except the placenta. These terminally differentiated cells generally do not change their fate in vivo. Some studies have shown that through nuclear transfer, cell fusion and co-cultivation of pluripotent cell extracts, terminally differentiated cells can be re-differentiated into a pluripotent state (Yamanaka S, Blau HM, 2010, Nuclear reprogramming to a pluripotent state by three approaches. Nature 465:704-712). However, these methods all rely on oocytes as a scarce material, so they are limited in application.
[0003] In 2006, Yamanaka used retroviral vectors to overexpress four exogenous transcri...